Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial

IMPORTANCE: Clinically used breast cancer markers, such as tumor size, tumor grade, progesterone receptor (PR) status, and Ki-67 status, are known to be associated with short-term survival, but the association of these markers with long-term (25-year) survival is unclear. OBJECTIVE: To assess the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Dar, Huma, Johansson, Annelie, Nordenskjöld, Anna, Iftimi, Adina, Yau, Christina, Perez-Tenorio, Gizeh, Benz, Christopher, Nordenskjöld, Bo, Stål, Olle, Esserman, Laura J., Fornander, Tommy, Lindström, Linda S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246315/
https://www.ncbi.nlm.nih.gov/pubmed/34190995
http://dx.doi.org/10.1001/jamanetworkopen.2021.14904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246315/
https://www.ncbi.nlm.nih.gov/pubmed/34190995
http://dx.doi.org/10.1001/jamanetworkopen.2021.14904

Ejemplares similares